We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-1.4%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$45.6B
AUM Growth
-$2.97B
(-6.1%)
Cap. Flow
-$1.56B
Cap. Flow
% of AUM
-3.42%
Top 10 Holdings %
Top 10 Hldgs %
10.17%
Holding
4,085
New
718
Increased
950
Reduced
874
Closed
814
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$352M |
| 2 |
Kroger
KR
|
+$279M |
| 3 |
AT&T
T
|
+$235M |
| 4 |
Intel
INTC
|
+$217M |
| 5 |
Edwards Lifesciences
EW
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$461M |
| 2 |
Merck
MRK
|
+$459M |
| 3 |
Coca-Cola
KO
|
+$295M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$283M |
| 5 |
TSMC
TSM
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.08% |
| 2 | Technology | 16.14% |
| 3 | Healthcare | 15.45% |
| 4 | Consumer Discretionary | 9.74% |
| 5 | Consumer Staples | 5.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Salesforce
CRM
$134B
| $21.6M | 0.05% |
150,491
+143,728
| +2,125% | +$24.4M |
|
427
Omega Healthcare
OHI
$15.4B
| $21.6M | 0.05% |
733,913
+109,736
| +18% | +$3.44M |
|
428
Waste Management
WM
$95.9B
| $21.6M | 0.05% |
135,012
-271,299
| -67% | -$44.8M |
|
429
Adobe
ADBE
$89.5B
| $21.5M | 0.05% |
78,261
+76,791
| +5,224% | +$29.1M |
|
430
Arrow Electronics
ARW
$10.9B
| $21.4M | 0.05% |
232,580
+75,070
| +48% | +$8.19M |
|
|
DAY
431
DELISTED
Dayforce
DAY
| $21.3M | 0.05% |
381,802
+329,833
| +635% | +$19.2M |
|
|
VAQC
432
DELISTED
Vector Acquisition Corporation II Class A Ordinary Shares
VAQC
| $21.1M | 0.05% |
2,122,701
+122,600
| +6% | +$1.21M |
|
|
NAAC
433
DELISTED
North Atlantic Acquisition Corporation Class A Ordinary Share
NAAC
| $21M | 0.05% |
2,106,129
-423,812
| -17% | -$4.19M |
|
434
RTX Corp
RTX
$287B
| $20.9M | 0.05% |
255,679
-342,239
| -57% | -$31M |
|
|
CCV
435
DELISTED
Churchill Capital Corp V
CCV
| $20.9M | 0.05% |
2,106,739
+9
| +0% | +$89 |
|
|
ACQR
436
DELISTED
Independence Holdings Corp. Class A Ordinary Share
ACQR
| $20.8M | 0.05% |
2,100,302
+1,543
| +0.1% | +$15.2K |
|
|
AVAN
437
DELISTED
Avanti Acquisition Corp.
AVAN
| $20.8M | 0.05% |
2,077,320
| – | – |
|
438
Itaú Unibanco
ITUB
$91.3B
| $20.8M | 0.05% |
+4,557,385
| New | +$19.4M |
|
439
Murphy Oil
MUR
$5.58B
| $20.8M | 0.05% |
+591,161
| New | +$20.4M |
|
440
Denali Therapeutics
DNLI
$3.67B
| $20.7M | 0.05% |
675,870
-141,780
| -17% | -$4.61M |
|
441
Yum! Brands
YUM
$41B
| $20.7M | 0.05% |
194,377
+101,417
| +109% | +$11.8M |
|
442
F5
FFIV
$22.1B
| $20.6M | 0.05% |
142,363
-88,132
| -38% | -$14M |
|
443
Driven Brands
DRVN
$2.25B
| $20.6M | 0.05% |
734,751
+682,931
| +1,318% | +$21M |
|
444
Freshpet
FRPT
$2.83B
| $20.5M | 0.05% |
+409,610
| New | +$19.3M |
|
|
HMCO
445
DELISTED
HumanCo Acquisition Corp. Class A Common Stock
HMCO
| $20.5M | 0.04% |
2,056,980
+250,000
| +14% | +$2.48M |
|
446
Clarivate
CLVT
$1.3B
| $20.5M | 0.04% |
2,180,213
+2,033,051
| +1,382% | +$25.7M |
|
447
Envoy Medical
COCH
$51M
| $20.5M | 0.04% |
2,080,871
| – | – |
|
|
FINM
448
DELISTED
Marlin Technology Corporation Class A Ordinary Share
FINM
| $20.4M | 0.04% |
2,053,169
+140,000
| +7% | +$1.39M |
|
449
Snap
SNAP
$7.32B
| $20.4M | 0.04% |
2,079,723
+644,028
| +45% | +$7.49M |
|
450
Insulet
PODD
$11.3B
| $20.4M | 0.04% |
88,891
-429,685
| -83% | -$108M |
|
Similar funds
Marshall Wace's Q3 2022 Portfolio in Review
As of Q3 2022, Marshall Wace held 4,085 positions worth $45.6B, down 6.1% from $48.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace withdrew a net $1.56B in Q3 2022, closing 814 positions and reducing 874 holdings. Its most notable exit was General Dynamics, an estimated $122M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Marshall Wace opened a new position in Albertsons Companies worth $84.6M.
- Marshall Wace's largest Q3 2022 buy was Albertsons Companies: 3,404,097 shares worth $84.6M.
- Marshall Wace added most to JPMorgan Chase in Q3 2022, an estimated $352M increase.
- Marshall Wace's biggest Q3 2022 reduction was UnitedHealth, cutting an estimated $461M.
- Marshall Wace fully exited General Dynamics in Q3 2022, selling an estimated $122M.
- Marshall Wace's ten largest holdings make up 10% of its $45.6B portfolio in Q3 2022.
- Marshall Wace opened 718 new positions and closed 814 in Q3 2022.
- Marshall Wace's portfolio value fell 6.1% quarter-over-quarter to $45.6B.
Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.